DOACs in the treatment of cancer-associated thrombosis
Since the publication of the SELECT-D trial1 and the Hokusai-VTE Cancer study2, there has been a shift in the...
AUTHORS
Floris Bosch
Department of Internal Medicine, Tergooi Hospital, Hilversum, The Netherlands
Floris Bosch graduated in medicine at the University of Amsterdam in 2016. During his studies he did research work for the vascular medicine department and the neurology department in the Amsterdam University Medical Center and he did a research internship at University College London in the National Hospital for Neurology and Neurosurgery. He worked as a resident in internal medicine until 2018. After this he worked as a resident in emergency medicine in Mungra Medical Center in Suriname. In 2018 he started his PhD in vascular medicine. His main topics are thrombosis in cancer patients and thrombosis in cirrhosis.
Floris Bosch graduated in medicine at the University of Amsterdam in 2016. During his studies he did research work for the vascular medicine department and the neurology department in the Amsterdam University Medical Center and he did a research internship at University College London in the National Hospital for Neurology and Neurosurgery. He worked as a resident in internal medicine until 2018. After this he worked as a resident in emergency medicine in Mungra Medical Center in Suriname. In 2018 he started his PhD in vascular medicine. His main topics are thrombosis in cancer patients and thrombosis in cirrhosis.